Home › Stocks › CGEM › All Fund Holders
CGEM — CULLINAN THERAPEUTICS INC · All Fund Holders
Funds holding (latest): 38 · Reported value held: $294.16M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| BlackRock Inc history | Q2 2026 | 5.23M | $95.29M | 0.00% | Add |
| Vanguard Group history | Q4 2025 | 3.30M | $34.14M | 0.00% | Add |
| Geode Capital Management history | Q2 2026 | 1.55M | $28.18M | 0.00% | Add |
| Goldman Sachs Group history | Q2 2026 | 1.00M | $18.24M | 0.01% | Add |
| Morgan Stanley history | Q2 2026 | 629.03K | $11.45M | 0.00% | Add |
| AQR Capital Management history | Q2 2026 | 581.34K | $10.59M | 0.00% | Add |
| Northern Trust Corp history | Q2 2026 | 571.08K | $10.40M | 0.00% | Add |
| Bank of America Corp history | Q2 2026 | 510.32K | $9.29M | 0.00% | Reduce |
| Charles Schwab Investment Management history | Q2 2026 | 464.03K | $8.45M | 0.00% | Add |
| Deutsche Bank AG history | Q2 2026 | 382.84K | $6.97M | 0.00% | Add |
| Millennium Management history | Q2 2026 | 366.23K | $6.67M | 0.00% | Hold |
| Renaissance Technologies history | Q2 2026 | 326.81K | $5.95M | 0.01% | Add |
| JPMorgan Chase & Co history | Q2 2026 | 282.63K | $5.21M | 0.00% | New |
| Two Sigma Investments history | Q2 2026 | 272.58K | $4.96M | 0.00% | Reduce |
| UBS Group AG history | Q2 2026 | 248.63K | $4.53M | 0.00% | Add |
| Fidelity Management & Research (FMR) history | Q2 2026 | 240.12K | $4.37M | 0.00% | Add |
| Moore Capital Management history | Q2 2026 | 189.95K | $3.46M | 0.05% | Add |
| BNY Mellon history | Q2 2026 | 171.03K | $3.11M | 0.00% | Add |
| Prudential Financial history | Q2 2026 | 167.56K | $3.05M | 0.00% | Add |
| Wellington Management Group history | Q2 2026 | 164.72K | $3.00M | 0.00% | Add |
| Balyasny Asset Management history | Q2 2024 | 150.71K | $2.63M | 0.01% | New |
| Invesco Ltd history | Q2 2026 | 143.55K | $2.61M | 0.00% | Reduce |
| Citigroup Inc history | Q2 2026 | 124.41K | $2.27M | 0.00% | Reduce |
| Manulife Financial history | Q2 2026 | 76.71K | $1.40M | 0.00% | Add |
| Point72 Asset Management history | Q2 2026 | 75.01K | $1.37M | 0.01% | Reduce |
| Marshall Wace history | Q2 2026 | 66.05K | $1.20M | 0.00% | Reduce |
| Norges Bank Investment Management history | Q4 2022 | 101.90K | $1.08M | 0.00% | New |
| Wells Fargo & Co history | Q2 2026 | 51.26K | $933.37K | 0.00% | Add |
| Citadel Advisors history | Q2 2026 | 50.50K | $919.61K | 0.00% | Reduce |
| Franklin Resources history | Q2 2026 | 42.34K | $771.10K | 0.00% | New |
| MFS Investment Management history | Q2 2026 | 31.71K | $577.49K | 0.00% | New |
| Legal & General Investment Management America history | Q2 2026 | 27.48K | $500.36K | 0.00% | Add |
| Janus Henderson Group history | Q1 2026 | 18.53K | $263.19K | 0.00% | Hold |
| D. E. Shaw & Co history | Q4 2025 | 14.37K | $148.68K | 0.00% | Reduce |
| Principal Global Investors history | Q4 2023 | 10.69K | $108.95K | 0.00% | Reduce |
| T. Rowe Price Associates history | Q2 2026 | 3.83M | $69.67K | 0.01% | Add |
| Amundi US history | Q1 2025 | 40 | $300 | 0.00% | Hold |
| PNC Financial Services history | Q2 2026 | 15 | $273 | 0.00% | Reduce |